Glaxosmithkline Regulatory News (GSK)

Name of applicant:

GlaxoSmithKline plc

Name of scheme:

GlaxoSmithKline plc 2017 Deferred Annual Bonus Plan

Period of return:

From:

1 November 2021

To:

30 April 2022

Balance of unallotted securities under scheme(s) from previous return:

265,519

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

221,300

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

44,219

Name of applicant:

GlaxoSmithKline plc

Name of scheme:

GlaxoSmithKline plc Share Save Plan 2012

Period of return:

From:

1 November 2021 

To:

30 April 2022

Balance of unallotted securities under scheme(s) from previous return:

3,069,147

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

1,695,652

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

1,373,495

Name of contact:

Victoria Whyte

Telephone number of contact:

020 8047 5000